Index
By TNW
About Index
Trending news
Analyze
Pricing
Sign up or sign in
UniQure
Work at UniQure?
Add yourself to this profile
1345
UniQure
uniQure is a world leader in the development of human gene based therapies for hemophilia B, acute intermittent porphyria, Parkinson’s disease and SanfilippoB.
Edit Profile
uniqure.com
Technology
>
Biotechnology
B2c
Founded in
2012
Raised
$78M
More info
Elsewhere
Also headquartered in Amsterdam
Royal Philips
TomTom
TNW
iCulture
Startupbootcamp FinTech & CyberSecurity
Emerce
ING Group
Tweakers
StartupJuncture
Fairphone
Companies in the same industry
MedAvail
BioNano Genomics
Cerevast
EffRx
Bikanta
GrayBug
Pulmatrix
Pennington Biomedical Research Center
AmnioChor
LUMA D.A.C.
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Latest funding
Debt financing
$20,000,000
Hercules Technology Growth Capital
Private equity
$58,000,000
Coller Capital
Employees
Team size
50+
Locations
HQ
Amsterdam
,
The Netherlands
Headquarters
Xconomy
UniQure to Yank Pioneering Gene Therapy From Market in Europe
Health
Science
Xconomy
Struggling UniQure Cuts Gene Therapies, Jobs, in Big Restructuring
Health
Strategy
The Motley Fool
,
Xconomy
Here's Why uniQure N.V.'s Stock Spiked Today --
Royal Philips
TomTom
TNW
iCulture
Startupbootcamp FinTech & CyberSecurity
Emerce
ING Group
Tweakers
StartupJuncture
Fairphone
MedAvail
BioNano Genomics
Cerevast
EffRx
Bikanta
GrayBug
Pulmatrix
Pennington Biomedical Research Center
AmnioChor
LUMA D.A.C.